ASH 46th (2004)

Drupal spam blocked by CleanTalk.
Title Content type
No Signs of New Toxicity When Amphotericin B Lipid Complex (ABLC, ABELCET) and Caspofungin Are Used in Combination in the Treatment of FUO. (click for details)
Infections after CD34-Selected or Unmanipulated Autologous Hematopoietic Stem Cell Transplantation. (click for details)
T-Cell Depletion and No Post-Transplant Immune Suppression Provides Better Immune Recovery to Aspergillus Than Conventional T Cell-Replete Hematopoietic Transplants. (click for details)
Cladribine (CdA) or Fludarabine (F) or High-Dose Intermittent Chlorambucil (Chl) as First-Line Treatment of Symptomatic Chronic Lymphocytic Leukemia? First Interim Analysis of Data from the International Randomized Phase III Trial. (click for details)
Long Term Infectious Complications Following Reduced Intensity Conditioning (RIC)Allogeneic HLA-Identical Sibling Transplantation (allo-SCT). (click for details)
Empirical Antifungal Therapy (Rx) with Caspofungin (CAS) vs Liposomal Amphotericin B (L-AmB) for Persistently Febrile Neutropenic Patients (Pts) with Acute Myeloid Leukemia (AML). (click for details)
Unusual Presentation of Chronic Myelogenous Leukemia Concomitant with Mycobacterium Avium Complex Infection. (click for details)
Incidence of Invasive Aspergillosis in Allogeneic Stem Cell Transplantation Patients: An Italian Prospectic Multicenter Study. (click for details)
Influence of Pretreatment with Amphotericin B on Treatement-Related Mortality (TRM) Following Allogeneic Stem Cell Transplantations (click for details)
Conventional Hospital Room Is as Safe as Sterile Unit for High-Dose Chemotherapy and Peripheral Blood Stem Cells (PBSC) Transplantation. (click for details)

Pages

Subscribe to ASH 46th (2004)